These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13802440)

  • 81. Synthesis and evaluation of N-heteroarylsubstituted triazolosulfonamides as carbonic anhydrase inhibitors.
    Balci A; Arslan M; Nixha AR; Bilen C; Ergun A; Gençer N
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):377-82. PubMed ID: 25068730
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
    Yaseen R; Ekinci D; Senturk M; Hameed AD; Ovais S; Rathore P; Samim M; Javed K; Supuran CT
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1337-41. PubMed ID: 26804228
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
    Bertucci A; Innocenti A; Zoccola D; Scozzafava A; Tambutté S; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):5054-8. PubMed ID: 19520577
    [TBL] [Abstract][Full Text] [Related]  

  • 84. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK; Bano S; Supuran CT; Khadikar PV
    Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The effect of intravenously administered 6063, the carbonic anhydrase inhibitor, 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide, on fluid and electrolytes in normal subjects and patients with congestive heart failure.
    FRIEDBERG CK; HALPERN M; TAYMOR R
    J Clin Invest; 1952 Dec; 31(12):1074-81. PubMed ID: 13011199
    [No Abstract]   [Full Text] [Related]  

  • 86. [Action of different types of sulfamides in the survival of Mytilus edulis explants].
    Benex J
    C R Acad Hebd Seances Acad Sci D; 1969 Jan; 268(1):158-61. PubMed ID: 4975867
    [No Abstract]   [Full Text] [Related]  

  • 87. [Pharmacology of 5-acetylimino-4-ethyl-delta2-1,3,4-thiadiazoline-2-sulfonamide (etazolamide, A-115), a new potent inhibitor of carbonic anhydrase. Note I. Preliminary studies on diuretic activity].
    PALA G; SGUANCI A
    Arch Ital Sci Farmacol; 1960 Jan; 10():58-69. PubMed ID: 14429871
    [No Abstract]   [Full Text] [Related]  

  • 88. [Possible interpretation of the mechanism of the renal action of carbonic anhydrase inhibitors].
    MARRO F
    Minerva Nefrol; 1960; 7():89-91. PubMed ID: 13767135
    [No Abstract]   [Full Text] [Related]  

  • 89. [Therapy by carbonic anhydrase inhibition].
    LUDWIG L
    Arzneimittelforschung; 1961 May; 11():486-92. PubMed ID: 13764085
    [No Abstract]   [Full Text] [Related]  

  • 90. [Antitussive effect of the inhibition of carbonic anhydrase].
    JIMENEZ-VARGAS J; BALAGUE A; SARRIA J
    Rev Esp Fisiol; 1961 Mar; 17():1-10. PubMed ID: 13790091
    [No Abstract]   [Full Text] [Related]  

  • 91. Relations between pharmacologic activity and molecular structure of certain saliuretic sulfonamides.
    CRAWFORD JD; FROST L; WELSH M; TERRY ML
    J Pharmacol Exp Ther; 1962 Mar; 135():382-93. PubMed ID: 13882061
    [No Abstract]   [Full Text] [Related]  

  • 92. [Research on carbonic anhydrase inhibitors].
    LESPAGNOL A; OSTEUX R; BAR D
    Bull Soc Chim Biol (Paris); 1961; 43():789-99. PubMed ID: 14464337
    [No Abstract]   [Full Text] [Related]  

  • 93. [Carbonic anhydrase inhibitors in therapy].
    DANILOVIC S
    Med Arh; 1960; 14():67-75. PubMed ID: 13814012
    [No Abstract]   [Full Text] [Related]  

  • 94. A comparative study of some carbonic anhydrase inhibitors.
    WOODFORD VR; LEEGWATER N; DRANCE SM
    Can J Biochem Physiol; 1961 Feb; 39():287-95. PubMed ID: 13786530
    [No Abstract]   [Full Text] [Related]  

  • 95. [Physicochemical and pharmacological properties of some N1-substituted sulfanilamides].
    MOIRAGHI A; SANSALVADORE F; ANGELETTIE ; DIMODICA G
    Boll Chim Farm; 1961 Nov; 100():811-23. PubMed ID: 14475101
    [No Abstract]   [Full Text] [Related]  

  • 96. [Pyrazole sulfanilamides. II. Isomers in positions 3 and 4 of 1-phenyl-5-(p-aminobenzenesulfonamido)-pyrazole and methoxysulfanilamidopyrazoles].
    ALBERTI C
    Farmaco Sci; 1961 Jul; 16():557-70. PubMed ID: 14448268
    [No Abstract]   [Full Text] [Related]  

  • 97. [Urea should increase the potency of sulfamides].
    BRUSSELMANS P
    Belg Tijdschr Geneesk; 1950 Jan; 6(2):89. PubMed ID: 15404138
    [No Abstract]   [Full Text] [Related]  

  • 98. [Relation between structure, action and protein binding in the 2-sulfanilamidopyrimidine series].
    HORSTMANN H; KNOTT T; SCHOLTAN W; SCHRAUFSTAETTER E; WALTER A; WOERFFEL U
    Arzneimittelforschung; 1961 Aug; 11():682-4. PubMed ID: 14449054
    [No Abstract]   [Full Text] [Related]  

  • 99. On the mode of action of sulfonamides.
    GERUNDO M
    Hawaii Med J; 1947; 7(2):118-21. PubMed ID: 18919097
    [No Abstract]   [Full Text] [Related]  

  • 100. [ON POSOLOGY OF SOCALLED LOW DOSE SULFAMIDES].
    CAIRELLA M
    Clin Ter; 1965 Mar; 32():555-9. PubMed ID: 14331670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.